Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
2674
-
Total 13F shares, excl. options
-
1.28B
-
Shares change
-
-21.2M
-
Total reported value, excl. options
-
$139B
-
Value change
-
-$2.12B
-
Put/Call ratio
-
0.83
-
Number of buys
-
1140
-
Number of sells
-
-1204
-
Price
-
$109.02
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q2 2023
2,896 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q2 2023.
ABBOTT LABORATORIES - COM (ABT) has 2,674 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.28B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (156M shares), BlackRock Inc. (137M shares), Capital Research Global Investors (77.2M shares), STATE STREET CORP (74.8M shares), Capital International Investors (59.2M shares), MORGAN STANLEY (36.4M shares), GEODE CAPITAL MANAGEMENT, LLC (31.9M shares), WELLINGTON MANAGEMENT GROUP LLP (29.9M shares), NORTHERN TRUST CORP (22.7M shares), and NORGES BANK (18.4M shares).
This table shows the top 2674 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.